Ufuk Avrupa · Horizon Europe (HORIZON)
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Çağrı özeti
Resmi metinden, ilk bölüm
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or cancer subtypes have access to tailored, promising biomarker-guided medicines or multi-modal treatment interventions via participation in subsequent clinical trials or national or regional compassionate use programmes by health authorities; Researchers, physicians, innovators [1] , startup, spin-off and spin-out companies, SMEs, charities or foundations and other professionals from different disciplines and sectors have access to innovative technology, medical devices or promising biomarker-guided medicines for further validation or commercialisation; National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries hav… devamı
Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomographyClinical ResearchCommon CancersHigh Income CountriesOncology NursesPrecision OncologyTumour BoardsTwinningWidening Countries
İlgili olabilecek akademisyenler
Konu uyumuna göre
30-
%64MAHMUT EMRE YILDIRIM
Ortak konular: Cancer Immunotherapy and Biomarkers · Inflammatory Biomarkers in Disease Prognosis · HER2/EGFR in Cancer Research · Breast Cancer Treatment Studies
Örtüşen yayınlar: Impact of Post-chemotherapy Radiotherapy on Survival Outcomes in Inoperable Malignant Mesothelioma: A Single-center Retrospective Analysis (2026) · Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study (2026)
-
%63HACER DEMİR
Ortak konular: Advanced Breast Cancer Therapies · Breast Cancer Treatment Studies · HER2/EGFR in Cancer Research · Inflammatory Biomarkers in Disease Prognosis
Örtüşen yayınlar: Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study (2023) · Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer (2017)
-
%61SEMA TÜRKER
Ortak konular: HER2/EGFR in Cancer Research · Inflammatory Biomarkers in Disease Prognosis · Advanced Breast Cancer Therapies · Gastric Cancer Management and Outcomes
Örtüşen yayınlar: Real-world outcomes of trastuzumab deruxtecan in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study (2026) · Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis (2026)
-
%60CEM HOROZOĞLU
Ortak konular: Cancer Immunotherapy and Biomarkers · Cancer-related molecular mechanisms research · RNA modifications and cancer · Galectins and Cancer Biology
Örtüşen yayınlar: Quantitative Analysis of CD27/CD70 Protein Expression and Investigation of Related Mechanisms in the Tumor Microenvironment of NSCLC (2025) · Investigation of Long Non-coding RNAs H19 and LINC00675 in Colorectal Cancers in Terms of Histopathological Features and Correlations With Plasma Markers (2022)
-
%59MURAT KURT
Ortak konular: Cancer Immunotherapy and Biomarkers · Bladder and Urothelial Cancer Treatments · Statistical Methods in Clinical Trials
Örtüşen yayınlar: Effect of pre processing methods on bond strength between acrylic resin teeth and acrylic denture base resin (2012) · Resin cements effect on the final color of novel monolithic CAD/CAM restorations (2018)
-
%59İSMAİL BEYPINAR
Ortak konular: Cancer Immunotherapy and Biomarkers · Bladder and Urothelial Cancer Treatments · Ferroptosis and cancer prognosis
Örtüşen yayınlar: Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors (2026) · LOCALIZE SCROTAL KAPOSI SARCOMA IN A HIV-NEGATIVE PATIENT (2025)
-
%58MEDİ KORİ
Ortak konular: Cancer-related molecular mechanisms research · Ferroptosis and cancer prognosis · RNA modifications and cancer
Örtüşen yayınlar: Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types (2022) · Molecular signatures of ovarian diseases: Insights from network medicine perspective (2016)
-
%56KÜBRA SENA BAŞ TOPCU
Ortak konular: Cancer Immunotherapy and Biomarkers
Örtüşen yayınlar: Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells (2025) · Heterocyclic compounds with different moieties: synthesis and evaluation of biological activities assisted with the computational study (2023)
-
%54AHMET ÖZET
Ortak konular: Cancer Immunotherapy and Biomarkers · Gastric Cancer Management and Outcomes · Colorectal Cancer Treatments and Studies · Cancer Diagnosis and Treatment
Örtüşen yayınlar: Predictive Value of the Royal Marsden Hospital Score in Second-line Immunotherapy for Metastatic NSCLC (2025) · Impact of Serum GDF-15 and IL-6 on Immunotherapy Response in Cancer: A Prospective Study (2024)
-
%54BİLGİ ERBAY KIZILARSLAN
Ortak konular: Cancer-related Molecular Pathways · Cancer Research and Treatments
-
%54EZGİ NURDAN YENİLMEZ TUNOĞLU
Ortak konular: Cancer-related molecular mechanisms research
Örtüşen yayınlar: Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis (2023) · Metabolite-Induced Apoptosis by Gundelia tournefortii in A549 Lung Cancer Cells: A Cytotoxic and Gene Expression Study (2025)
-
%54MURAT IHLAMUR
Ortak konular: Cancer Immunotherapy and Biomarkers
Örtüşen yayınlar: Overcoming resistance to immune checkpoint inhibitors in cancer: translational mechanisms, dynamic biomarkers, clinically actionable combination strategies, and comparative checkpoint biology (2026) · Applications of Exosome Vesicles in Different Cancer Types as Biomarkers (2024)
-
%54ŞİRİN ÇETİN
Ortak konular: COVID-19 Clinical Research Studies · Pancreatic and Hepatic Oncology Research · Inflammatory Biomarkers in Disease Prognosis
Örtüşen yayınlar: Evaluation of Death Risks of Lung Cancer Patients with Frailty Models (2020) · Evaluation of Death Risks of Lung Cancer Patients with Frailty Models (2020)
-
%53EMİN DEMİREL
Ortak konular: COVID-19 Clinical Research Studies
Örtüşen yayınlar: Exploring the Role of Peritumoral Edema in Predicting Lung Cancer Subtypes Through T2-FLAIR Digital Subtraction Imaging of Metastatic Brain Tumors (2025) · Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis (2023)
-
%53ERHAN APTULLAHOĞLU
Ortak konular: Cancer-related Molecular Pathways · Advanced Breast Cancer Therapies
Örtüşen yayınlar: RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia (2024) · p53 as a biomarker and potential target in gastrointestinal stromal tumors (2022)
-
%53YILDIZ OKUTURLAR
Ortak konular: COVID-19 Clinical Research Studies · Inflammatory Biomarkers in Disease Prognosis
Örtüşen yayınlar: Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study. (2018) · Effect of adding taxane to platin-5-fluorouracil combination on survival in elderly patients with advanced gastric cancer: A retrospective-multicenter study. (2017)
-
%53ÖZGE GÜMÜŞAY
Ortak konular: Advanced Breast Cancer Therapies · HER2/EGFR in Cancer Research · Breast Cancer Treatment Studies · Cancer Diagnosis and Treatment
Örtüşen yayınlar: Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases Study of the Anatolian Society of Medical Oncology (2012) · Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment (2016)
-
%52BURHAN TURGUT
Ortak konular: Cancer Immunotherapy and Biomarkers
Örtüşen yayınlar: The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer (2025) · Measurable Residual Disease in Chronic Lymphocytic Leukemia: Experience in Real-Life Setting with Dry Tube Flow Cytometric Method (2022)
-
%52KÜBRA TEMİZ
Ortak konular: Cancer Immunotherapy and Biomarkers
Örtüşen yayınlar: Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma (2023) · Exploring the TRIM15 protein interaction network as a drug target using machine learning in pancreatic cancer (2025)
-
%52MUSTAFA ERKİN ARIBAL
Ortak konular: Breast Cancer Treatment Studies · Global Cancer Incidence and Screening · AI in cancer detection
Örtüşen yayınlar: Improvement of early detection of breast cancer through collaborative multi-country efforts: Medical physics component (2018) · Radiologic findings of screen detected cancers in an organized population based screening mammography program in Turkey (2016)
-
%52YASİN SEZGİN
Ortak konular: Gastric Cancer Management and Outcomes · Cancer Immunotherapy and Biomarkers · Cancer Treatment and Pharmacology · Cancer Diagnosis and Treatment
Örtüşen yayınlar: Prognostıc Factors In Testıcular Cancer (2024) · Effect of vitamin D on prognosis in patients with gastric cancer (2024)
-
%51BAŞAK ADAKLI AKSOY
Ortak konular: Childhood Cancer Survivors' Quality of Life · COVID-19 Clinical Research Studies
Örtüşen yayınlar: Precision oncology in practice: Real-world multicenter experience with larotrectinib in pediatric extracranial NTRK fusion–positive tumors. (2026) · Invasive Saprochaete capitata Infection in a Patient with Autosomal Recessive CARD9 Deficiency and a Review of the Literature (2020)
-
%51CEYHAN CERAN SERDAR
Ortak konular: Cancer Immunotherapy and Biomarkers · COVID-19 Clinical Research Studies
Örtüşen yayınlar: Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients (2023) · From Personalized to Multi-Patient: Shared Sequences of Female Reproductive System Cancer Neoepitopes withOther Cancer Neoepitopes for Refurbished Vaccine Candidates (Data Mining-Based Study) (2026)
-
%51CEYHAN HACIOĞLU
Ortak konular: Ferroptosis and cancer prognosis · Sirtuins and Resveratrol in Medicine
Örtüşen yayınlar: Borax induces ferroptosis of glioblastoma by targeting HSPA5/NRF2/GPx4/GSH pathways (2024) · Boric Acid Induces Oxidative Damage and Apoptosis Through SEMA3A/PLXNA1/NRP1 Signalling Pathway in U251 Glioblastoma Cell (2025)
-
%51DAVUT ŞAHİN
Ortak konular: Cancer and biochemical research · Cervical Cancer and HPV Research · Pancreatic and Hepatic Oncology Research
Örtüşen yayınlar: Yüksek Risk HPV Pozitif, PAP Testi Negatif Vakalarda İlave Bir Sıvı Bazlı Sitoloji Preperatının Sitolojik Tanıya Etkisi (2019) · Diagnostic cytological features and differential diagnosisof subacute granulomatous (De Quervain’xxs) thyroiditis (2019)
-
%51NUR EKİMCİ GÜRCAN
Ortak konular: Cancer Cells and Metastasis · COVID-19 Clinical Research Studies
Örtüşen yayınlar: Identifying the therapeutic role of CD90 as a key player in cancer treatment foraggressive tumours (2025) · Deciphering the Structural and Molecular Effects of a Novel Genetic Mutation by In Silico Analysis in Chordoma Cell Line (2026)
-
%51ZAFER SÖYLEMEZ
Ortak konular: RNA modifications and cancer
Örtüşen yayınlar: Investigation of the expression levels of CDH1, FHIT, PTEN and TTPAL genes in colorectal tumors (2022) · Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3,EIF4A1, IFN?, 1 PIK3CA and CTNNB1 genes in different stage colorectal tumors. (2021)
-
%51ÖZLEM ERCELEP
Ortak konular: Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment · Inflammatory Biomarkers in Disease Prognosis
Örtüşen yayınlar: The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification (2017) · Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer (2016)
-
%50ERCAN KARAARSLAN
Ortak konular: Prostate Cancer Diagnosis and Treatment · MRI in cancer diagnosis · Prostate Cancer Treatment and Research
-
%50ERTAN KÜÇÜKSAYAN
Ortak konular: Cancer, Lipids, and Metabolism
Örtüşen yayınlar: Hybrid Compounds as Multitarget Directed Anticancer Agents (2017) · Elevated level of neuroserpin is an indication for the resistance to gambogic acid-induced apoptosis and oxidative stress in triple-negative breast cancer cells (2024)
Uyum oranı kodla, her istekte hesaplanır. Çağrı metni (başlık, anahtar kelimeler, resmi açıklamanın başı) şu üç kaynakla karşılaştırılır: akademisyen profiliyle anlamsal yakınlık (%50), YÖKSİS anahtar kelimeleri ve OpenAlex konularındaki ortak ayırt edici terimler (%25) ve yayın içeriği — başlıklar, İngilizce özetler ve bunların Türkçe çevirileri (%25). Çeviriler sayesinde Türkçe çağrılar İngilizce yayınlarla da eşleşir. Yaygın kelimeler düşük ağırlıklıdır; %40 altı gösterilmez. Bir konu önerisidir; başvuru uygunluğu, kapasite ya da başarı değerlendirmesi değildir. Gizli profiller listelenmez.